Anti-epileptic drugs-induced de novo absence seizures

Brain and Development

Volumn 25, Issue 1, 2003, Pages 51-56

  Yang, Ming Tao ^a   Lee, Wang Tso ^a   Chu, Li Wen ^a   Shen, Yu Zen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Absence epilepsy; Carbamazepine; Children; Vigabatrin

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; CONVULSION; ELECTROENCEPHALOGRAPHY; EPILEPTOGENESIS; FEBRILE CONVULSION; FEMALE; HUMAN; HYPERVENTILATION; MALE; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; THALAMOCORTICAL TRACT; TREATMENT OUTCOME;

EID: 0037248924     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0387-7604(02)00120-1     Document Type: Article

References (32)

1. Zaccara G., Muscas G.C., Messori A. Clinical features, pathogenesis and management of drug-induced seizures. Drug Saf. 5:1990;109-151.
2. Garcia P.A., Alldredge B.K. Drug-induced seizures. Neurol Clin. 1:1994;85-99.
3. Bauer J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand. 94:1996;367-377.
4. Perucca E., Gram L., Avanzini G., Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia. 39:1998;5-17.
5. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia. 27:1986;706-710.
6. Gambardella A., Aguglia U., Guerrini R., Morelli F., Zappia M., Quattrone A. Sequential occurrence of benign partial epilepsy and childhood absence epilepsy in three patients. Brain Dev. 18:1996;212-215.
7. Shields W.D., Saslow E. Myoclonic, atonic and absence seizures following institution of carbamazepine therapy in children. Neurology. 33:1983;1487-1489.
8. Johnsen S.D., Tarby T.J., Sidell A.D. Carbamazepine-induced seizures. Ann Neurol. 16:1984;392-393.
9. Liporace J.D., Sperling M.R., Dichter M.A. Absence seizures and carbamazepine in adults. Epilepsia. 35:1994;1026-1028.
10. Cocito L., Primavera A. Vigabatrin aggravates absences and absence status. Neurology. 51:1998;1519.
11. Knake S., Hamer H.M., Schomburg U., Oertel W.H., Rosenow F. Tiagabine-induced absence status in idiopathic generalized epilepsy. Seizure. 8:1999;314-317.
12. Bray F.P., Wiser W.C. A unifying concept of idiopathic epilepsy. Postgrad Med. 46:1969;82-87.
13. Beaumanoir A., Nahory A. Les epilepsies benignes partielles: 11 cases d'epilepsie partielle frontal à évolution favorable. Rev EEG Neurophysiol. 13:1983;207-211.
14. Genton P., Guerrini R. Lack of association between childhood absence epilepsy and idiopathic partial epilepsy of childhood. Epilepsia. 34:1993;S88.
15. Huguenard J.R., Coulter D.A., Prince D.A. Physiology of thalamic relay neurons. Avol M., Gloor P., Kostopoulos G., Napuet R. Generalized epilepsy. 1990;181-189 Birkhauser, Boston, MA.
16. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus: new evidence of anatomical and physiologic specificity. Physiol Rev. 63:1983;844-914.
17. Hosford D.A., Clark S., Cao Z., Wilson W.A., Lin F.H., Morriset R.A., et al. The role of GABA B receptor activation in absence seizures of lethargic (lh/lh) mice. Science. 257:1992;398-401.
18. Snead O.C. Evidence for GABA B-mediated mechanisms in experimental generalized absence seizures. Eur J Pharmacol. 213:1992;343-349.
19. Marescaux C., Vergnes M., Bernasconi R. GABA B receptor antagonists: potential new anti-absence drugs. J Neural Transm. 35:(Suppl.):1992;179-188.
20. Meldrum B.S., Horton R.W. Neuronal inhibition mediated GABA and patterns of convulsions in baboons with photosensitive epilepsy (Papio papio). Harris P., Mawdsley C. Epilepsy. 1974;55-64 Churchill Livingstone, Edinburgh.
21. Golden G.T., Fariello R.G. Epileptogenic action of some direct GABA agonists: effects of manipulation of the GABA and glutamate systems. Fariello R.G. Neurotransmitters, seizures and epilepsy II. 1984;237-244 Raven Press, New York.
22. Nugent S., Katz D., Little T.E. Baclofen overdoses with cardiac conduction abnormalities: case report and review of the literature. Clin Toxicol. 24:1986;321-328.
23. Paulson G.W. Overdose of lioresal. Neurology. 26:1979;1105-1106.
24. Rodin E.A., Rim C.S., Rennick P.M. The effects of Tegretol on the EEG. Electroenceph clin Neurophysiol. 37:1976;329.
25. Steriade M., Curro Dossi R., Nunez A. Network modulation of a slow intrinsic oscillation of cat thalamocortical neurons implicated in sleep delta waves: cortically-induced synchronization and brainstem cholinergic suppression. J Neurosci. 11:1991;3200-3217.
26. Snead O.C., Hosey L.C. Exacerbation of seizures in children by carbamazepine. N Engl J Med. 313:1985;916-921.
27. Lortie A., Chiron C., Mumford J., Dulac O. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Neurology. 43:(Suppl. 5):1993;S24-S27.
28. Grant S.M., Heel R.C. Vigabatrin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs. 41:1991;889-926.
29. Vogt H., Stotz G. Response to vigabatrin in relation to seizure type in symptomatic generalized epilepsies (Lennox-Gastaut syndrome). Epilepsia. 37:(Suppl. 5):1996;S24-S27.
30. Luna D., Dulac O., Pajot N., Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia. 30:1989;430-437.
31. Roseman E. Dilantin toxicity: a clinical and electroencephalographic study. Neurology. 11:1961;912-921.
32. Talwar D., Maninder S.A., Phyllis K.S. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia. 35:1994;1154-1159.